Nicofuranose

Nicofuranose

Clinical data
ATC code	C10AD03 (WHO)
Identifiers
IUPAC name [(2R,3S,4R,5R)-2-hydroxy-4-(pyridine-3-carbonyloxy)-2,5-bis(pyridine-3-carbonyloxymethyl)oxolan-3-yl] pyridine-3-carboxylate
PubChem CID	25495
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C30H24N4O10
Molar mass	600.533 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

For patient information, click here

Nicofuranose is a niacin derivative used as a hypolipidemic agent.

Template:Lipid modifying agents

Template:WikiDoc Sources